Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal ropivacaine for postoperative pain after laparoscopic bariatric surgery
ACTRN12618000389202Phase 4Completed
- Sponsor
- Dr Nicholas Williams
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Dr Nicholas Williams. Primary endpoint: Postoperative pain. Started Jan 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12618000389202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000389202.